Corindus, developer of remote control technology for the cardiac catheterization laboratory, holds a patent for “Remote Control Catheterization” technology. Its CorPath catheter manipulation system allows physicians to advance and torque coronary guide wires and stent systems in a patient’s artery from a remote location. The system is noninvasive and accommodates all interventional cath lab devices.
Corindus recently announced the opening of U.S. headquarters in Auburndale, MA, for the management of sales, marketing and clinical affairs. Originally established in 2002 as NaviCath, the company was founded within the framework of the Technion Entrepreneurial Incubator Company (TEIC) in Haifa, Israel.
March 18, 2024 
